344 related articles for article (PubMed ID: 30227093)
1. Comparison of 0.025% FK-506, 0.05% Cyclosporin A, and 0.3% Sodium Hyaluronate Eye Drops for the Treatment of Botulinum Toxin B-Induced Mouse Dry Eye.
Lin BW; Huang WL; Wang L; Chen ZM
J Ocul Pharmacol Ther; 2018 Nov; 34(9):633-641. PubMed ID: 30227093
[TBL] [Abstract][Full Text] [Related]
2. Effect of 0.025% FK-506 eyedrops on botulinum toxin B-induced mouse dry eye.
Lin BW; Chen MZ; Fan SX; Chuck RS; Zhou SY
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):45-53. PubMed ID: 25491293
[TBL] [Abstract][Full Text] [Related]
3. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Zhu L; Zhang C; Chuck RS
Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
[TBL] [Abstract][Full Text] [Related]
4. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of 0.05% cyclosporine A combined with vitamin A palmitate in the treatment of meibomian gland dysfunction-related dry eye].
Hao YR; Li SY; Bao JY; Wang JY; Li A; Tian L; Jie Y
Zhonghua Yan Ke Za Zhi; 2024 Feb; 60(2):127-136. PubMed ID: 38296318
[No Abstract] [Full Text] [Related]
6. Effects of topical anti-inflammatory agents in a botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
Lekhanont K; Park CY; Smith JA; Combs JC; Preechawat P; Suwan-Apichon O; Rangsin R; Chuck RS
J Ocul Pharmacol Ther; 2007 Feb; 23(1):27-34. PubMed ID: 17341147
[TBL] [Abstract][Full Text] [Related]
7. Effect of topical olopatadine and epinastine in the botulinum toxin B-induced mouse model of dry eye.
Lekhanont K; Park CY; Combs JC; Suwan-Apichon O; Rangsin R; Chuck RS
J Ocul Pharmacol Ther; 2007 Feb; 23(1):83-8. PubMed ID: 17341156
[TBL] [Abstract][Full Text] [Related]
8. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS
Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035
[TBL] [Abstract][Full Text] [Related]
9. Effect of Single Instillation of Two Hyaluronic Acid-Based Topical Lubricants on Tear Film Thickness in Patients with Dry Eye Syndrome.
Szegedi S; Scheschy U; Schmidl D; Aranha Dos Santos V; Stegmann H; Adzhemian N; Fondi K; Bata AM; Werkmeister RM; Couderc C; Schmetterer L; Garhofer G
J Ocul Pharmacol Ther; 2018 Nov; 34(9):605-611. PubMed ID: 30325687
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye.
Choi JH; Kim JH; Li Z; Oh HJ; Ahn KY; Yoon KC
Korean J Ophthalmol; 2015 Apr; 29(2):131-7. PubMed ID: 25829831
[TBL] [Abstract][Full Text] [Related]
11. Lacrimal gland inflammatory cytokine gene expression in the botulinum toxin B-induced murine dry eye model.
Park CY; Zhuang W; Lekhanont K; Zhang C; Cano M; Lee WS; Gehlbach PL; Chuck RS
Mol Vis; 2007 Nov; 13():2222-32. PubMed ID: 18087241
[TBL] [Abstract][Full Text] [Related]
12. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye.
Li Z; Choi JH; Oh HJ; Park SH; Lee JB; Yoon KC
Curr Eye Res; 2014 Sep; 39(9):871-8. PubMed ID: 24559509
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
Suwan-apichon O; Rizen M; Rangsin R; Herretes S; Reyes JM; Lekhanont K; Chuck RS
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):133-9. PubMed ID: 16384954
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Inflammation-Related Genes in the Cornea of a Mouse Model of Dry Eye upon Treatment with Cyclosporine Eye Drops.
Daull P; Barabino S; Feraille L; Kessal K; Docquier M; Parsadaniantz SM; Baudouin C; Garrigue JS
Curr Eye Res; 2019 May; 44(5):476-485. PubMed ID: 30664361
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride].
He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG
Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 0.3% Hypotonic and Isotonic Sodium Hyaluronate Eye Drops in the Treatment of Experimental Dry Eye.
Li Y; Cui L; Lee HS; Kang YS; Choi W; Yoon KC
Curr Eye Res; 2017 Aug; 42(8):1108-1114. PubMed ID: 28441078
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model.
Zhu L; Shen J; Zhang C; Park CY; Kohanim S; Yew M; Parker JS; Chuck RS
Mol Vis; 2009; 15():250-8. PubMed ID: 19190733
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye.
You IC; Li Y; Jin R; Ahn M; Choi W; Yoon KC
J Ocul Pharmacol Ther; 2018 Oct; 34(8):557-564. PubMed ID: 30036099
[TBL] [Abstract][Full Text] [Related]
19. Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye.
Moon JW; Lee HJ; Shin KC; Wee WR; Lee JH; Kim MK
Korean J Ophthalmol; 2007 Dec; 21(4):189-94. PubMed ID: 18063881
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new lipid tear substitute in a mouse model of dry eye.
Scifo C; Barabino S; De Pasquale G; Blanco AR; Mazzone MG; Rolando M
Cornea; 2010 Jul; 29(7):802-6. PubMed ID: 20489574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
